---
figid: PMC6479799__ijms-20-01673-g002
figlink: /pmc/articles/PMC6479799/figure/ijms-20-01673-f002/
number: F2
caption: 'Mechanism of CB-R-mediated antitumor activity in breast cancer cells. By
  binding to CB1-R and CB2-R, CBs inhibit breast cancer cell proliferation through
  various mechanisms. They block cell cycle progression at the G1/S phase via CB1-R
  and at the G2/M phase via CB2-R activation. They induce breast cancer cell death
  via apoptosis, mediated by the activation of the transcription factor jun-D. In
  HER2-overexpressing breast cancer cells, they block cancer cell proliferation in
  culture and tumors by inhibiting Akt and ERK signaling. They also inhibit cell migration
  and angiogenesis via CB2-R. CB1-R activation inhibits the FAK/SRC/RhoA pathway leading
  to inhibition of cell migration. Cell migration blockade is also achieved by CB2-R
  activation through the inhibition of COX-2 and ERK signaling, which is important
  for triple-negative breast cancer. AC: adenylate cyclase; Akt: protein kinase B;
  CB-R: cannabinoid receptor; COX-2: cyclooxygenase-2; EMT: epithelial-mesenchymal
  transition; ERK: extracellular-signal-regulated kinase; FAK: focal adhesion kinase;
  GPR: G-protein coupled receptor; HER2: human epidermal growth factor receptor 2:
  MAPK: mitogen-activated protein kinase; mTOR: mammalian target of rapamycin; PI3K:
  Phosphoinositol-3-kinase; Raf: serine/threonine-protein kinase; RhoA: transforming
  protein RhoA; SRC: proto-oncogene tyrosine-protein kinase Src.'
pmcid: PMC6479799
papertitle: Future Aspects for Cannabinoids in Breast Cancer Therapy.
reftext: Terézia Kisková, et al. Int J Mol Sci. 2019 Apr;20(7):1673.
pmc_ranked_result_index: '15307'
pathway_score: 0.9545493
filename: ijms-20-01673-g002.jpg
figtitle: Mechanism of CB-R-mediated antitumor activity in breast cancer cells
year: '2019'
organisms:
- Homo sapiens
ndex: c74ef879-dea6-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6479799__ijms-20-01673-g002.html
  '@type': Dataset
  description: 'Mechanism of CB-R-mediated antitumor activity in breast cancer cells.
    By binding to CB1-R and CB2-R, CBs inhibit breast cancer cell proliferation through
    various mechanisms. They block cell cycle progression at the G1/S phase via CB1-R
    and at the G2/M phase via CB2-R activation. They induce breast cancer cell death
    via apoptosis, mediated by the activation of the transcription factor jun-D. In
    HER2-overexpressing breast cancer cells, they block cancer cell proliferation
    in culture and tumors by inhibiting Akt and ERK signaling. They also inhibit cell
    migration and angiogenesis via CB2-R. CB1-R activation inhibits the FAK/SRC/RhoA
    pathway leading to inhibition of cell migration. Cell migration blockade is also
    achieved by CB2-R activation through the inhibition of COX-2 and ERK signaling,
    which is important for triple-negative breast cancer. AC: adenylate cyclase; Akt:
    protein kinase B; CB-R: cannabinoid receptor; COX-2: cyclooxygenase-2; EMT: epithelial-mesenchymal
    transition; ERK: extracellular-signal-regulated kinase; FAK: focal adhesion kinase;
    GPR: G-protein coupled receptor; HER2: human epidermal growth factor receptor
    2: MAPK: mitogen-activated protein kinase; mTOR: mammalian target of rapamycin;
    PI3K: Phosphoinositol-3-kinase; Raf: serine/threonine-protein kinase; RhoA: transforming
    protein RhoA; SRC: proto-oncogene tyrosine-protein kinase Src.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SRC
  - ADCY3
  - AKT1
  - CTNNB1
  - ADCY6
  - ADCY1
  - AKT3
  - ADCY5
  - SNAI1
  - AKT2
  - ADCY2
  - PIK3R4
  - PIK3CA
  - CBR1
  - PIK3R5
  - MAPK1
  - PTK2
  - GPR55
  - MAPK3
  - RHOA
  - SNAI2
  - ADCY10
  - MTOR
  - MAP2K1
  - PIK3R6
  - PIK3R3
  - PIK3CB
  - PIK3CD
  - BRAF
  - ARAF
  - PIK3CG
  - RAF1
  - MAP2K2
  - ADCY7
  - ADCY9
  - ADCY4
  - ADCY8
  - JUND
  - TWIST1
  - Ceramide
  - Cancer
genes:
- word: SRC
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY3
  entrez: '109'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: B-Catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY6
  entrez: '112'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY1
  entrez: '107'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY5
  entrez: '111'
- word: Snail1,
  symbol: SNAIL1
  source: hgnc_alias_symbol
  hgnc_symbol: SNAI1
  entrez: '6615'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY2
  entrez: '108'
- word: P13K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: P13K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: CB-R1
  symbol: CBR1
  source: hgnc_symbol
  hgnc_symbol: CBR1
  entrez: '873'
- word: P13K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: FAK
  symbol: FAK
  source: hgnc_alias_symbol
  hgnc_symbol: PTK2
  entrez: '5747'
- word: GPR55
  symbol: GPR55
  source: hgnc_symbol
  hgnc_symbol: GPR55
  entrez: '9290'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: RHOA
  symbol: RHOA
  source: hgnc_symbol
  hgnc_symbol: RHOA
  entrez: '387'
- word: Slug,
  symbol: SLUG
  source: hgnc_prev_symbol
  hgnc_symbol: SNAI2
  entrez: '6591'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY10
  entrez: '55811'
- word: mTor
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: MEK1/2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: P13K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: P13K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: P13K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: P13K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: P13K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY7
  entrez: '113'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY9
  entrez: '115'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY4
  entrez: '196883'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY8
  entrez: '114'
- word: JUND
  symbol: JUND
  source: hgnc_symbol
  hgnc_symbol: JUND
  entrez: '3727'
- word: ISnail1,Slug,Twist
  symbol: TWIST
  source: hgnc_prev_symbol
  hgnc_symbol: TWIST1
  entrez: '7291'
chemicals:
- word: Ceramide
  source: MESH
  identifier: D002518
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC6479799__F2
redirect_from: /figures/PMC6479799__F2
figtype: Figure
---
